Abstract Background Obesity is associated with cardiovascular complications, including pulmonary hypertension (PH). Reports suggest that peroxisome proliferator-activated receptor-γ (PPARγ) has direct action in preventing vascular remodelling in PH. Here we dissected the specific role of high-fat-diet (HFD)-induced obesity and vascular smooth muscle cell (VSMC)-PPARγ for remodelling of small pulmonary arteries. Methods Wild-type (WT) and VSMC-specific PPARγ-knockout (SmPparγ −/−) mice were fed a low-fat-diet (LFD, 10% kcal from fat) or HFD (60% kcal from fat) for 24 weeks. Mice were metabolically phenotyped (e.g. weight development, insulin/glucose tolerance) at the beginning, and after 12 and 24 weeks, respectively. At 24 weeks additionall...
International audienceBackground Platelet‐derived growth factor is a major regulator of the vascular...
Pulmonary hypertension is an umbrella term including many different disorders causing an increase of...
BACKGROUND: Weight loss in obese insulin-resistant but not in insulin-sensitive persons reduces coro...
Obesity and insulin resistance (IR) are well-studied risk factors for systemic cardiovascular diseas...
Background—Patients with pulmonary arterial hypertension (PAH) have reduced expression of apolipopro...
Vascular remodeling is the fundamental basis for hypertensive disease, in which vascular smooth musc...
SummaryPeroxisome proliferator-activated receptor γ (PPARγ) is a ligand-activated transcription fact...
Activation of the nuclear hormone receptor, PPARγ, with pharmacological agonists promotes a contract...
<div><p>Activation of the nuclear hormone receptor, PPARγ, with pharmacological agonists promotes a ...
Abstract—Vascular expression of bone morphogenetic type IA receptor (Bmpr1a) is reduced in lungs of ...
SummaryThe role of the peroxisome proliferator-activated receptor-α (PPARα) in the development of in...
Remodeling of the pulmonary arteries is a common feature among the heterogeneous disorders that caus...
10 pages; Present address of G. Hansmann: Dept. of Cardiology, Children's Hospital Boston, Harvard M...
Peroxisome proliferator activated receptor γ (PPARγ) has been reported to play a protective role in ...
BackgroundMany patients with heart failure with preserved ejection fraction have metabolic syndrome ...
International audienceBackground Platelet‐derived growth factor is a major regulator of the vascular...
Pulmonary hypertension is an umbrella term including many different disorders causing an increase of...
BACKGROUND: Weight loss in obese insulin-resistant but not in insulin-sensitive persons reduces coro...
Obesity and insulin resistance (IR) are well-studied risk factors for systemic cardiovascular diseas...
Background—Patients with pulmonary arterial hypertension (PAH) have reduced expression of apolipopro...
Vascular remodeling is the fundamental basis for hypertensive disease, in which vascular smooth musc...
SummaryPeroxisome proliferator-activated receptor γ (PPARγ) is a ligand-activated transcription fact...
Activation of the nuclear hormone receptor, PPARγ, with pharmacological agonists promotes a contract...
<div><p>Activation of the nuclear hormone receptor, PPARγ, with pharmacological agonists promotes a ...
Abstract—Vascular expression of bone morphogenetic type IA receptor (Bmpr1a) is reduced in lungs of ...
SummaryThe role of the peroxisome proliferator-activated receptor-α (PPARα) in the development of in...
Remodeling of the pulmonary arteries is a common feature among the heterogeneous disorders that caus...
10 pages; Present address of G. Hansmann: Dept. of Cardiology, Children's Hospital Boston, Harvard M...
Peroxisome proliferator activated receptor γ (PPARγ) has been reported to play a protective role in ...
BackgroundMany patients with heart failure with preserved ejection fraction have metabolic syndrome ...
International audienceBackground Platelet‐derived growth factor is a major regulator of the vascular...
Pulmonary hypertension is an umbrella term including many different disorders causing an increase of...
BACKGROUND: Weight loss in obese insulin-resistant but not in insulin-sensitive persons reduces coro...